Here are five things to know:
1. The Ventura NanoMetalene is a transforaminal intervertebral body fusion device. It is commercially available and has been successfully implanted in patients.
2. The device is indicated for use as an adjunct to fusion in patients with degenerative disc disease and builds on the company’s Hollywood NanoMetalene interbody device.
3. The NanoMetalene is an ultra-thin layer of commercially pure titanium molecularly bonded to PEEK-OPTIMA implants.
4. The company collaborated with surgeon partners to create the implant, designed to use instrumentation that already exists for spinal procedures. Surgeons are able to create a secure anatomical fit with the device and Ventura NanoMetalene’s large graft aperture for autogenous bone graft assists in fusion.
5. SeaSpine received FDA clearance for several other NanoMetalene coated PEEK interbody devices in its current portfolio. The company plans to launch the additional products in future periods.
More articles on orthopedic devices:
5 key notes on Invuity’s new CFO
FDA clears MAKO technology for total knee replacement
K2M, InVivo Therapeutics, Zimmer & more—19 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
